Insights
Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.
December 24, 2019 –
Jose Martinez, MD, discusses management strategies of diabetic retinopathy.
December 18, 2019 –
Final thoughts on unmet needs in the management of BCC and CSCC and how to approach future treatment of these diseases.
December 18, 2019 –
Second-line therapy options for BCC treatment are reviewed, and current clinical trials on cemiplimab and pembrolizumab are evaluated.
December 18, 2019 –
The safety and efficacy of hedgehog inhibitors sonidegib and vismodegib are examined in the systemic treatment of BCC.
December 18, 2019 –
An overview of cutaneous squamous cell carcinoma (CSCC), including diagnosis, distinguishing CSCC from head and neck cancer, and risk factors for developing advanced disease.
November 04, 2019 –
Experts provide insight on when patients may not be surgical candidates and potential complications that can follow surgery when approaching treatment of basal cell carcinoma.
November 04, 2019 –
An overview of basal cell carcinoma considering differential diagnoses and the current standard of care.
October 28, 2019 –
A closer look into the adverse effect profile and pseudoprogession of immunotherapy when treating patients with CSCC.
October 28, 2019 –
Key opinion leaders discuss the positive impact of cemiplimab in their personal practices along with the off-label use of pembrolizumab and cetuximab in CSCC management.
October 21, 2019 –
The benefit of using immunotherapy for the treatment of CSCC and a review of cemiplimab in Study 1540.
